{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:02:05Z","timestamp":1790694125405,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":1526,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010738","name":"Ablynx NV","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1074\/jbc.m115.684241","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T17:18:47Z","timestamp":1464023927000},"page":"15243-15255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency Improvement"],"prefix":"10.1016","volume":"291","author":[{"given":"Evelyn","family":"De Tavernier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Detalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Morizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Roobrouck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"De Taeye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Verhaeghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Van Hegelsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Figueirido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Noens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"St\u00f6hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Van de Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Depla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Dombrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M115.684241_bib1","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.ddtec.2010.03.002","article-title":"Nanobodies: from llamas to therapeutic proteins","volume":"7","author":"Kolkman","year":"2010","journal-title":"Drug Discov. Today Technol"},{"key":"10.1074\/jbc.M115.684241_bib2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem"},{"key":"10.1074\/jbc.M115.684241_bib3","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/art.21827","article-title":"Formatted anti-tumor necrosis factor \u03b1 VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis","volume":"54","author":"Coppieters","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1074\/jbc.M115.684241_bib4","doi-asserted-by":"crossref","first-page":"20565","DOI":"10.1073\/pnas.1012865107","article-title":"CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells","volume":"107","author":"J\u00e4hnichen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.684241_bib5","doi-asserted-by":"crossref","first-page":"e17665","DOI":"10.1371\/journal.pone.0017665","article-title":"Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules","volume":"6","author":"Hultberg","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M115.684241_bib6","doi-asserted-by":"crossref","first-page":"e109367","DOI":"10.1371\/journal.pone.0109367","article-title":"Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice","volume":"9","author":"Terryn","year":"2014","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M115.684241_bib7","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.4161\/19420862.2014.975099","article-title":"Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction","volume":"6","author":"Huet","year":"2014","journal-title":"mAbs"},{"key":"10.1074\/jbc.M115.684241_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/mol.114.094821","article-title":"Potent and efficacious inhibition of CXCR2 signaling by biparatopic nanobodies combining two distinct modes of action","volume":"87","author":"Bradley","year":"2015","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M115.684241_bib9","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/ijc.26145","article-title":"A biparatopic anti-EGFR Nanobody efficiently inhibits solid tumour growth","volume":"129","author":"Roovers","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.M115.684241_bib10","doi-asserted-by":"crossref","first-page":"29562","DOI":"10.1074\/jbc.M113.498436","article-title":"Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo","volume":"288","author":"Maussang","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.684241_bib11","series-title":"Severe Infections Caused by Pseudomonas Aeruginosa","first-page":"1","article-title":"Pseudomonas aeruginosa infections in specific types of patients and clinical settings","author":"Stryjewski","year":"2003"},{"key":"10.1074\/jbc.M115.684241_bib12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijantimicag.2015.03.001","article-title":"Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology","volume":"45","author":"Potron","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1074\/jbc.M115.684241_bib13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrmicro2199","article-title":"The type III secretion system of Pseudomonas aeruginosa: infection by injection","volume":"7","author":"Hauser","year":"2009","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1074\/jbc.M115.684241_bib14","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1128\/IAI.68.5.2916-2924.2000","article-title":"Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils","volume":"68","author":"Dacheux","year":"2000","journal-title":"Infect. Immun"},{"key":"10.1074\/jbc.M115.684241_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2958.2001.02368.x","article-title":"Pore-forming activity of type III system-secreted proteins leads to oncosis of Pseudomonas aeruginosa-infected macrophages","volume":"40","author":"Dacheux","year":"2001","journal-title":"Mol. Microbiol"},{"key":"10.1074\/jbc.M115.684241_bib16","doi-asserted-by":"crossref","first-page":"e81792","DOI":"10.1371\/journal.pone.0081792","article-title":"In the absence of effector proteins, the Pseudomonas aeruginosa type three secretion system needle tip complex contributes to lung injury and systemic inflammatory responses","volume":"8","author":"Audia","year":"2013","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M115.684241_bib17","doi-asserted-by":"crossref","first-page":"23940","DOI":"10.1074\/jbc.M803146200","article-title":"Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis","volume":"283","author":"G\u00e9bus","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.684241_bib18","doi-asserted-by":"crossref","first-page":"e1002163","DOI":"10.1371\/journal.ppat.1002163","article-title":"Crystal structure of PrgI-SipD: insight into a secretion competent state of the type three secretion system needle tip and its interaction with host ligands","volume":"7","author":"Lunelli","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.M115.684241_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fmicb.2011.00142","article-title":"Multi-functional characteristics of the Pseudomonas aeruginosa type III needle-tip protein, PcrV: comparison to orthologs in other Gram-negative bacteria","volume":"2","author":"Sato","year":"2011","journal-title":"Front. Microbiol"},{"key":"10.1074\/jbc.M115.684241_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/MMBR.05017-11","article-title":"Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria","volume":"76","author":"B\u00fcttner","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev"},{"key":"10.1074\/jbc.M115.684241_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/1348-0421.12147","article-title":"V-antigen homologs in pathogenic Gram-negative bacteria","volume":"58","author":"Sawa","year":"2014","journal-title":"Microbiol. Immunol"},{"key":"10.1074\/jbc.M115.684241_bib22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/7391","article-title":"Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M115.684241_bib23","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1128\/IAI.72.8.4741-4750.2004","article-title":"The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB\/PopD translocation pore in host cell membranes","volume":"72","author":"Goure","year":"2004","journal-title":"Infect. Immun"},{"key":"10.1074\/jbc.M115.684241_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.micpath.2004.10.005","article-title":"Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN","volume":"37","author":"Sundin","year":"2004","journal-title":"Microb Pathog"},{"key":"10.1074\/jbc.M115.684241_bib25","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1365-2958.2009.07027.x","article-title":"Control of effector export by the Pseudomonas aeruginosa type III secretion proteins PcrG and PcrV","volume":"75","author":"Lee","year":"2010","journal-title":"Mol. Microbiol"},{"key":"10.1074\/jbc.M115.684241_bib26","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1096\/fj.13-229054","article-title":"A novel effector secretion mechanism based on proton-motive force-dependent type III secretion apparatus rotation","volume":"27","author":"Ohgita","year":"2013","journal-title":"FASEB J"},{"key":"10.1074\/jbc.M115.684241_bib27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/430932","article-title":"Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes","volume":"192","author":"Goure","year":"2005","journal-title":"J. Infect. Dis"},{"key":"10.1074\/jbc.M115.684241_bib28","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1128\/IAI.69.9.5908-5910.2001","article-title":"PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice","volume":"69","author":"Holder","year":"2001","journal-title":"Infect. Immun"},{"key":"10.1074\/jbc.M115.684241_bib29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1348-0421.2009.00165.x","article-title":"Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice","volume":"53","author":"Moriyama","year":"2009","journal-title":"Microbiol. Immunol"},{"key":"10.1074\/jbc.M115.684241_bib30","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/IAI.00815-08","article-title":"An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity","volume":"77","author":"Baer","year":"2009","journal-title":"Infect. Immun"},{"key":"10.1074\/jbc.M115.684241_bib31","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1128\/AAC.02643-14","article-title":"A novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models","volume":"58","author":"Warrener","year":"2014","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.M115.684241_bib32","doi-asserted-by":"crossref","first-page":"262ra155","DOI":"10.1126\/scitranslmed.3009655","article-title":"A multifunctional bispecific antibody protects against Pseudomonas aeruginosa","volume":"6","author":"DiGiandomenico","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"10.1074\/jbc.M115.684241_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00262-006-0180-4","article-title":"Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR nanobodies","volume":"56","author":"Roovers","year":"2007","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1074\/jbc.M115.684241_bib34","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1099\/mic.0.28277-0","article-title":"Factors triggering type III secretion in Pseudomonas aeruginosa","volume":"151","author":"Kim","year":"2005","journal-title":"Microbiology"},{"key":"10.1074\/jbc.M115.684241_bib35","first-page":"301","article-title":"The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague","volume":"12","author":"Derewenda","year":"2004","journal-title":"Structure"},{"key":"10.1074\/jbc.M115.684241_bib36","doi-asserted-by":"crossref","first-page":"12529","DOI":"10.1073\/pnas.0602689103","article-title":"Molecular model of a type III secretion system needle: implications for host-cell sensing","volume":"103","author":"Deane","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.684241_bib37","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/jac\/dkr038","article-title":"Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection","volume":"66","author":"Secher","year":"2011","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1074\/jbc.M115.684241_bib38","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/bioinformatics\/bti516","article-title":"Statistics of protein library construction","volume":"21","author":"Firth","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1074\/jbc.M115.684241_bib39","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.4049\/jimmunol.167.10.5880","article-title":"Therapeutic administration of anti-PcrV F(ab\u2032)2 in sepsis associated with Pseudomonas aeruginosa","volume":"167","author":"Shime","year":"2001","journal-title":"J. Immunol"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820412670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820412670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M115.684241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T11:11:37Z","timestamp":1641294697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820412670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":39,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0021925820412670"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m115.684241","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency Improvement","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M115.684241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}